64 related articles for article (PubMed ID: 13742397)
1. [2-Sulfanilamido-3-methoxypyrazine. Chemical, physicochemical, biological and therapeutic characteristics].
ROCCHIETTA S
Boll Chim Farm; 1961 Apr; 100():279-81. PubMed ID: 13742397
[No Abstract] [Full Text] [Related]
2. CHEMICAL PHARMACOLOGY OF 2-SULFANILAMIDO-3-METHOXYPYRAZINE.
WIEGAND RG; CHUN AH; SCHERFLING E; LOPEZ F; HERTING RL
Antimicrob Agents Chemother (Bethesda); 1964; 10():549-53. PubMed ID: 14287991
[No Abstract] [Full Text] [Related]
3. CLINICAL PHARMACOLOGY OF 2-SULFANILAMIDO-3-METHOXYPYRAZINE.
HERTING RL; LOPEZ F; SCHERFLING E; SYLVESTER JC; WIEGAND R
Antimicrob Agents Chemother (Bethesda); 1964; 10():554-61. PubMed ID: 14287992
[No Abstract] [Full Text] [Related]
4. 2-Sulfanilamido-3-methoxypyrazine: a new long-action sulfonamide.
CESANA A; VENTURA R
Panminerva Med; 1962 Apr; 4():184-7. PubMed ID: 13877775
[No Abstract] [Full Text] [Related]
5. Biologically active nuclear-substituted sulfonamides. I. Chemical and physical properties of some nuclear-substituted sulfanilamido-2-thiazoles and their syntheses.
QUAN SF; DANIELS TC; KUMLER WD
J Am Pharm Assoc Am Pharm Assoc; 1954 Jun; 43(6 1):321-6. PubMed ID: 13174427
[No Abstract] [Full Text] [Related]
6. [S-Sulfanilamido- and 3-sulfanilamido-1,2,4-thiadiazole].
WOERFFEL U; BEHNISCH R
Arch Pharm Ber Dtsch Pharm Ges; 1962 Nov; 295/67():811-6. PubMed ID: 14001457
[No Abstract] [Full Text] [Related]
7. [THERAPEUTIC ACTION OF 2-SULFANILAMIDO-5-METHOXYPYRIMIDINE ON SUBACUTE AND CHRONIC CHOLECYSTITIS].
VALENTI G; BELLODI G
Policlinico Prat; 1964 Aug; 71():1273-7. PubMed ID: 14192188
[No Abstract] [Full Text] [Related]
8. [Experimental therapeutic action of a new sulfonamide, 2-p-aminobenzene-sulfonamido-3-methoxypyrazine].
GHIONE M; BUOGO A; ZAVAGLIO V
Chemotherapia (Basel); 1963; 6():243-58. PubMed ID: 13947489
[No Abstract] [Full Text] [Related]
9. [PHARMACOKINETICS AND CLINICO-THERAPEUTIC EFFECTIVENESS OF 4-SULFANILAMIDO-5,6-DIMETHOXYPYRIMIDINE].
HITZENBERGER G
Wien Klin Wochenschr; 1964 May; 76():330-4. PubMed ID: 14222129
[No Abstract] [Full Text] [Related]
10. [Influencing of the tubular function in renal excretion of 4-sulfanilamido-2, 6-dimethylpyrimidine].
PORTWICH F; BUTTNER H
Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1956; 229(6):513-9. PubMed ID: 13407769
[No Abstract] [Full Text] [Related]
11. [Therapeutic activity of 2-sulfanilamido-3-methoxypyrazine in some dermatological diseases].
CALIFANO A
Minerva Med; 1961 May; 52():1817-9. PubMed ID: 13689962
[No Abstract] [Full Text] [Related]
12. [6-Sulfanilamido-2,4-dimethylpyrimidine; contribution to sulfonamide therapy].
KORNER H
Dtsch Gesundheitsw; 1950 Jun; 5(23):727-8. PubMed ID: 15427471
[No Abstract] [Full Text] [Related]
13. [Experimental studies on 2-sulfanilamido-5-methylpyrimidine].
HEPDING L; HOFFMANN A; WAHLIG H
Arzneimittelforschung; 1960 Jun; 10():440-8. PubMed ID: 14401170
[No Abstract] [Full Text] [Related]
14. [Early results of 3,4-dimethyl-5-sulfanilamido-isoxazole therapy of acute and chronic infections of the lung].
ANNEDDA L; ROMAGNANI L
Gazz Med Ital; 1953 May; 112(5):146-9. PubMed ID: 13083873
[No Abstract] [Full Text] [Related]
15. [Sulfapyrimidine in chemotherapy; clinical experiences with 6-sulfanilamido-2,4-dimethylpyrimidin, L 30 of Nordmark and Co..].
HAUCH HJ; LUDWIG L; MULHENS K
Z Gesamte Inn Med; 1950 Mar; 5(5-6):159-68. PubMed ID: 15425176
[No Abstract] [Full Text] [Related]
16. [PHARMACOKINETICS OF 2-SULFANILAMIDO-5-ETHYLPYRIMIDINE IN MAN].
PLANCHER AC; SALVI G; BACUZZI E
Farmaco Prat; 1964 Nov; 19():550-9. PubMed ID: 14234089
[No Abstract] [Full Text] [Related]
17. [Results obtained in 20 ambulatory patients treated with 2, 4-dimethoxy-6-sulfanilamido-1,3-diazine].
CABLINSKI E; CAMPANA JM
Sem Med; 1960 Jun; 116():1175-7. PubMed ID: 13689657
[No Abstract] [Full Text] [Related]
18. [2-Sulfanilamido-3-methoxypyrazine in the treatment of various inflammatory forms of the female genital tract].
DE CECCO L
Clin Ter; 1963 Mar; 24():543-51. PubMed ID: 14025743
[No Abstract] [Full Text] [Related]
19. Pharmacology of 4-azophenyl-sulfanilamido-o-butylphenol.
SAZONOVA NA
Farmakol Toksikol; 1945; 8(2):49. PubMed ID: 21000679
[No Abstract] [Full Text] [Related]
20. Pharmacological and chemotherapeutic properties of 3,4-dimethyl-5-sulfanilamido-isoxazole.
SCHNITZER RJ; FOSTER RH
J Pharmacol Exp Ther; 1946 Sep; 88(1):47-57. PubMed ID: 20274525
[No Abstract] [Full Text] [Related]
[Next] [New Search]
